 | • レポートコード：MRC2012A6907 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ペプチドの世界市場を広く調査・分析し、今後の市場展望をまとめております。ペプチドの種類別市場規模（インスリン、テリパラチド、リラグルチド、リュープロリド）、用途別市場規模（糖尿病、感染症、がん、骨粗鬆症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Cipla Ltd.、VHB Life Sciences Limited、Troikaa Pharmaceuticals Ltd.、Emcure Pharmaceuticals Pvt. Ltd.、Samarth Life Sciences Pvt. Ltd.、Gland Pharma Limited、United Biotech (P) Limited、Bharat Biotech、Biological E Limited、Celon Laboratories Pvt. Ltd.、 ・地域別グローバル市場分析 2015年-2020年 ・ペプチドの北米市場（アメリカ、カナダ、メキシコ） ・ペプチドのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ペプチドのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ペプチドの南米市場（ブラジル、アルゼンチン） ・ペプチドの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：インスリン、テリパラチド、リラグルチド、リュープロリド ・用途別分析：糖尿病、感染症、がん、骨粗鬆症 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Peptides market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Peptides market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Peptides market has been segmented into
Insulin
Teriparatide
Liraglutide
Leuprolide
By Application, Peptides has been segmented into:
Diabetes
Infectious Diseases
Cancer
Osteoporosis
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Peptides market presented in the report. This section sheds light on the sales growth of different regional and country-level Peptides markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Peptides market.
The report offers in-depth assessment of the growth and other aspects of the Peptides market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Peptides Market Share Analysis
Peptides competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Peptides sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Peptides sales, revenue and market share for each player covered in this report.
The major players covered in Peptides are:
Cipla Ltd.
VHB Life Sciences Limited
Troikaa Pharmaceuticals Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Samarth Life Sciences Pvt. Ltd.
Gland Pharma Limited
United Biotech (P) Limited
Bharat Biotech
Biological E Limited
Celon Laboratories Pvt. Ltd.
Among other players domestic and global, Peptides market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peptides product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Peptides, with price, sales, revenue and global market share of Peptides in 2018 and 2019.
Chapter 3, the Peptides competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peptides breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Peptides market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Peptides sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Peptides Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Peptides Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Insulin
1.2.3 Teriparatide
1.2.4 Liraglutide
1.2.5 Leuprolide
1.3 Market Analysis by Application
1.3.1 Overview: Global Peptides Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Cancer
1.3.5 Osteoporosis
1.4 Overview of Global Peptides Market
1.4.1 Global Peptides Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Cipla Ltd.
2.1.1 Cipla Ltd. Details
2.1.2 Cipla Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Cipla Ltd. SWOT Analysis
2.1.4 Cipla Ltd. Product and Services
2.1.5 Cipla Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 VHB Life Sciences Limited
2.2.1 VHB Life Sciences Limited Details
2.2.2 VHB Life Sciences Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 VHB Life Sciences Limited SWOT Analysis
2.2.4 VHB Life Sciences Limited Product and Services
2.2.5 VHB Life Sciences Limited Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Troikaa Pharmaceuticals Ltd.
2.3.1 Troikaa Pharmaceuticals Ltd. Details
2.3.2 Troikaa Pharmaceuticals Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Troikaa Pharmaceuticals Ltd. SWOT Analysis
2.3.4 Troikaa Pharmaceuticals Ltd. Product and Services
2.3.5 Troikaa Pharmaceuticals Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Emcure Pharmaceuticals Pvt. Ltd.
2.4.1 Emcure Pharmaceuticals Pvt. Ltd. Details
2.4.2 Emcure Pharmaceuticals Pvt. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Emcure Pharmaceuticals Pvt. Ltd. SWOT Analysis
2.4.4 Emcure Pharmaceuticals Pvt. Ltd. Product and Services
2.4.5 Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Samarth Life Sciences Pvt. Ltd.
2.5.1 Samarth Life Sciences Pvt. Ltd. Details
2.5.2 Samarth Life Sciences Pvt. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Samarth Life Sciences Pvt. Ltd. SWOT Analysis
2.5.4 Samarth Life Sciences Pvt. Ltd. Product and Services
2.5.5 Samarth Life Sciences Pvt. Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Gland Pharma Limited
2.6.1 Gland Pharma Limited Details
2.6.2 Gland Pharma Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Gland Pharma Limited SWOT Analysis
2.6.4 Gland Pharma Limited Product and Services
2.6.5 Gland Pharma Limited Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 United Biotech (P) Limited
2.7.1 United Biotech (P) Limited Details
2.7.2 United Biotech (P) Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 United Biotech (P) Limited SWOT Analysis
2.7.4 United Biotech (P) Limited Product and Services
2.7.5 United Biotech (P) Limited Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bharat Biotech
2.8.1 Bharat Biotech Details
2.8.2 Bharat Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bharat Biotech SWOT Analysis
2.8.4 Bharat Biotech Product and Services
2.8.5 Bharat Biotech Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biological E Limited
2.9.1 Biological E Limited Details
2.9.2 Biological E Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biological E Limited SWOT Analysis
2.9.4 Biological E Limited Product and Services
2.9.5 Biological E Limited Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Celon Laboratories Pvt. Ltd.
2.10.1 Celon Laboratories Pvt. Ltd. Details
2.10.2 Celon Laboratories Pvt. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Celon Laboratories Pvt. Ltd. SWOT Analysis
2.10.4 Celon Laboratories Pvt. Ltd. Product and Services
2.10.5 Celon Laboratories Pvt. Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Peptides Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Peptides Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Peptides Manufacturer Market Share in 2019
3.3.2 Top 6 Peptides Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Peptides Sales, Revenue and Market Share by Regions
4.1.1 Global Peptides Sales and Market Share by Regions (2015-2020)
4.1.2 Global Peptides Revenue and Market Share by Regions (2015-2020)
4.2 North America Peptides Sales and Growth Rate (2015-2020)
4.3 Europe Peptides Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Peptides Sales and Growth Rate (2015-2020)
4.5 South America Peptides Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Peptides Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Peptides Sales, Revenue and Market Share by Country
5.1.1 North America Peptides Sales and Market Share by Country (2015-2020)
5.1.2 North America Peptides Revenue and Market Share by Country (2015-2020)
5.2 United States Peptides Sales and Growth Rate (2015-2020)
5.3 Canada Peptides Sales and Growth Rate (2015-2020)
5.4 Mexico Peptides Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Peptides Sales, Revenue and Market Share by Country
6.1.1 Europe Peptides Sales and Market Share by Country (2015-2020)
6.1.2 Europe Peptides Revenue and Market Share by Country (2015-2020)
6.2 Germany Peptides Sales and Growth Rate (2015-2020)
6.3 UK Peptides Sales and Growth Rate (2015-2020)
6.4 France Peptides Sales and Growth Rate (2015-2020)
6.5 Russia Peptides Sales and Growth Rate (2015-2020)
6.6 Italy Peptides Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Peptides Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Peptides Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Peptides Revenue and Market Share by Regions (2015-2020)
7.2 China Peptides Sales and Growth Rate (2015-2020)
7.3 Japan Peptides Sales and Growth Rate (2015-2020)
7.4 Korea Peptides Sales and Growth Rate (2015-2020)
7.5 India Peptides Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Peptides Sales and Growth Rate (2015-2020)
7.7 Australia Peptides Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Peptides Sales, Revenue and Market Share by Country
8.1.1 South America Peptides Sales and Market Share by Country (2015-2020)
8.1.2 South America Peptides Revenue and Market Share by Country (2015-2020)
8.2 Brazil Peptides Sales and Growth Rate (2015-2020)
8.3 Argentina Peptides Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Peptides Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Peptides Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Peptides Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Peptides Sales and Growth Rate (2015-2020)
9.3 Turkey Peptides Sales and Growth Rate (2015-2020)
9.4 Egypt Peptides Sales and Growth Rate (2015-2020)
9.5 South Africa Peptides Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Peptides Sales and Market Share by Type (2015-2020)
10.2 Global Peptides Revenue and Market Share by Type (2015-2020)
10.3 Global Peptides Price by Type (2015-2020)
11 Global Peptides Market Segment by Application
11.1 Global Peptides Sales Market Share by Application (2015-2020)
11.2 Global Peptides Revenue Market Share by Application (2015-2020)
11.3 Global Peptides Price by Application (2015-2020)
12 Market Forecast
12.1 Global Peptides Sales, Revenue and Growth Rate (2021-2025)
12.2 Peptides Market Forecast by Regions (2021-2025)
12.2.1 North America Peptides Market Forecast (2021-2025)
12.2.2 Europe Peptides Market Forecast (2021-2025)
12.2.3 Asia-Pacific Peptides Market Forecast (2021-2025)
12.2.4 South America Peptides Market Forecast (2021-2025)
12.2.5 Middle East & Africa Peptides Market Forecast (2021-2025)
12.3 Peptides Market Forecast by Type (2021-2025)
12.3.1 Global Peptides Sales Forecast by Type (2021-2025)
12.3.2 Global Peptides Market Share Forecast by Type (2021-2025)
12.4 Peptides Market Forecast by Application (2021-2025)
12.4.1 Global Peptides Sales Forecast by Application (2021-2025)
12.4.2 Global Peptides Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Peptides Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Peptides by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Peptides Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Cipla Ltd. Basic Information, Manufacturing Base and Competitors
Table 8. Cipla Ltd. Peptides Major Business
Table 9. Cipla Ltd. Peptides Total Revenue (USD Million) (2017-2018)
Table 10. Cipla Ltd. SWOT Analysis
Table 11. Cipla Ltd. Peptides Product and Services
Table 12. Cipla Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. VHB Life Sciences Limited Basic Information, Manufacturing Base and Competitors
Table 14. VHB Life Sciences Limited Peptides Major Business
Table 15. VHB Life Sciences Limited Peptides Total Revenue (USD Million) (2017-2018)
Table 16. VHB Life Sciences Limited SWOT Analysis
Table 17. VHB Life Sciences Limited Peptides Product and Services
Table 18. VHB Life Sciences Limited Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Troikaa Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 20. Troikaa Pharmaceuticals Ltd. Peptides Major Business
Table 21. Troikaa Pharmaceuticals Ltd. Peptides Total Revenue (USD Million) (2017-2018)
Table 22. Troikaa Pharmaceuticals Ltd. SWOT Analysis
Table 23. Troikaa Pharmaceuticals Ltd. Peptides Product and Services
Table 24. Troikaa Pharmaceuticals Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Emcure Pharmaceuticals Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 26. Emcure Pharmaceuticals Pvt. Ltd. Peptides Major Business
Table 27. Emcure Pharmaceuticals Pvt. Ltd. Peptides Total Revenue (USD Million) (2017-2018)
Table 28. Emcure Pharmaceuticals Pvt. Ltd. SWOT Analysis
Table 29. Emcure Pharmaceuticals Pvt. Ltd. Peptides Product and Services
Table 30. Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Samarth Life Sciences Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. Samarth Life Sciences Pvt. Ltd. Peptides Major Business
Table 33. Samarth Life Sciences Pvt. Ltd. Peptides Total Revenue (USD Million) (2017-2018)
Table 34. Samarth Life Sciences Pvt. Ltd. SWOT Analysis
Table 35. Samarth Life Sciences Pvt. Ltd. Peptides Product and Services
Table 36. Samarth Life Sciences Pvt. Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Gland Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 38. Gland Pharma Limited Peptides Major Business
Table 39. Gland Pharma Limited Peptides Total Revenue (USD Million) (2017-2018)
Table 40. Gland Pharma Limited SWOT Analysis
Table 41. Gland Pharma Limited Peptides Product and Services
Table 42. Gland Pharma Limited Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. United Biotech (P) Limited Basic Information, Manufacturing Base and Competitors
Table 44. United Biotech (P) Limited Peptides Major Business
Table 45. United Biotech (P) Limited Peptides Total Revenue (USD Million) (2017-2018)
Table 46. United Biotech (P) Limited SWOT Analysis
Table 47. United Biotech (P) Limited Peptides Product and Services
Table 48. United Biotech (P) Limited Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 50. Bharat Biotech Peptides Major Business
Table 51. Bharat Biotech Peptides Total Revenue (USD Million) (2017-2018)
Table 52. Bharat Biotech SWOT Analysis
Table 53. Bharat Biotech Peptides Product and Services
Table 54. Bharat Biotech Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Biological E Limited Basic Information, Manufacturing Base and Competitors
Table 56. Biological E Limited Peptides Major Business
Table 57. Biological E Limited Peptides Total Revenue (USD Million) (2017-2018)
Table 58. Biological E Limited SWOT Analysis
Table 59. Biological E Limited Peptides Product and Services
Table 60. Biological E Limited Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Celon Laboratories Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 62. Celon Laboratories Pvt. Ltd. Peptides Major Business
Table 63. Celon Laboratories Pvt. Ltd. Peptides Total Revenue (USD Million) (2017-2018)
Table 64. Celon Laboratories Pvt. Ltd. SWOT Analysis
Table 65. Celon Laboratories Pvt. Ltd. Peptides Product and Services
Table 66. Celon Laboratories Pvt. Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Peptides Sales by Manufacturer (2018-2019) (K MT)
Table 68. Global Peptides Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Peptides Sales by Regions (2015-2020) (K MT)
Table 70. Global Peptides Sales Market Share by Regions (2015-2020)
Table 71. Global Peptides Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Peptides Sales by Countries (2015-2020) (K MT)
Table 73. North America Peptides Sales Market Share by Countries (2015-2020)
Table 74. North America Peptides Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Peptides Revenue Market Share by Countries (2015-2020)
Table 76. Europe Peptides Sales by Countries (2015-2020) (K MT)
Table 77. Europe Peptides Sales Market Share by Countries (2015-2020)
Table 78. Europe Peptides Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Peptides Sales by Regions (2015-2020) (K MT)
Table 80. Asia-Pacific Peptides Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Peptides Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Peptides Sales by Countries (2015-2020) (K MT)
Table 83. South America Peptides Sales Market Share by Countries (2015-2020)
Table 84. South America Peptides Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Peptides Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Peptides Sales by Countries (2015-2020) (K MT)
Table 87. Middle East & Africa Peptides Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Peptides Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Peptides Revenue Market Share by Countries (2015-2020)
Table 90. Global Peptides Sales by Type (2015-2020) (K MT)
Table 91. Global Peptides Sales Share by Type (2015-2020)
Table 92. Global Peptides Revenue by Type (2015-2020) (USD Million)
Table 93. Global Peptides Revenue Share by Type (2015-2020)
Table 94. Global Peptides Sales by Application (2015-2020) (K MT)
Table 95. Global Peptides Sales Share by Application (2015-2020)
Table 96. Global Peptides Sales Forecast by Regions (2021-2025) (K MT)
Table 97. Global Peptides Market Share Forecast by Regions (2021-2025)
Table 98. Global Peptides Sales Forecast by Type (2021-2025) (K MT)
Table 99. Global Peptides Market Share Forecast by Type (2021-2025)
Table 100. Global Peptides Sales Forecast by Application (2021-2025)
Table 101. Global Peptides Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Peptides Picture
Figure 2. Global Sales Market Share of Peptides by Type in 2019
Figure 3. Insulin Picture
Figure 4. Teriparatide Picture
Figure 5. Liraglutide Picture
Figure 6. Leuprolide Picture
Figure 7. Peptides Sales Market Share by Application in 2018
Figure 8. Diabetes Picture
Figure 9. Infectious Diseases Picture
Figure 10. Cancer Picture
Figure 11. Osteoporosis Picture
Figure 12. Global Peptides Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Peptides Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Peptides Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Peptides Sales Market Share by Manufacturer in 2019
Figure 33. Global Peptides Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Peptides Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Peptides Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 38. Global Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Peptides Revenue Market Share by Regions (2015-2020)
Figure 40. Global Peptides Revenue Market Share by Regions in 2018
Figure 41. North America Peptides Sales and Growth Rate (2015-2020)
Figure 42. Europe Peptides Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Peptides Sales and Growth Rate (2015-2020)
Figure 44. South America Peptides Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Peptides Sales and Growth Rate (2015-2020)
Figure 46. North America Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Peptides Sales Market Share by Countries (2015-2020)
Figure 48. North America Peptides Sales Market Share by Countries in 2018
Figure 49. North America Peptides Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Peptides Revenue Market Share by Countries in 2018
Figure 51. United States Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Canada Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Mexico Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Europe Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Peptides Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Peptides Revenue Market Share by Countries in 2019
Figure 57. Germany Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 58. UK Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 59. France Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Russia Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Italy Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Asia-Pacific Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Peptides Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Peptides Revenue Market Share by Regions 2019
Figure 65. China Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Japan Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Korea Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 68. India Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Southeast Asia Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 70. South America Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Peptides Sales Market Share by Countries in 2019
Figure 72. South America Peptides Revenue Market Share by Countries in 2019
Figure 73. Brazil Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Argentina Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Middle East and Africa Peptides Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Peptides Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Peptides Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Peptides Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Egypt Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Turkey Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 82. South Africa Peptides Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Global Peptides Sales and Growth Rate (2021-2025) (K MT)
Figure 84. Global Peptides Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Peptides Market Forecast (2021-2025) (K MT)
Figure 86. Europe Sales Peptides Market Forecast (2021-2025) (K MT)
Figure 87. Asia-Pacific Sales Peptides Market Forecast (2021-2025) (K MT)
Figure 88. South America Sales Peptides Market Forecast (2021-2025) (K MT)
Figure 89. Middle East & Africa Sales Peptides Market Forecast (2021-2025) (K MT)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
ペプチドの世界市場（～2026年） Market Analysis and Insights: Global Peptides Market The global Peptides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Peptides Scope and Market Size Peptides market is segmented by Type, and by Application. Players,…- ペプチド・ヘパリンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Peptides and Heparin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Peptides and Heparin mar…
- ペプチドバイオシミラーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Peptides Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Peptides Biosimilars mar…
- 組換えペプチドの世界市場（～2026年） Market Analysis and Insights: Global Recombinant Peptides Market The global Recombinant Peptides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Recombinant Peptides Scope and Market Size Recombinant Peptides market is…
- 抗炎症ペプチドの世界市場（～2026年） Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal's skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and…